# Airvo/Optiflow High Flow Nasal Oxygenation During Microlaryngeal Surgery

> **NCT02780518** · NA · WITHDRAWN · sponsor: **Singapore General Hospital**

## Conditions studied

- Throat Disorders

## Interventions

- **DEVICE:** Airvo

## Key facts

- **NCT ID:** NCT02780518
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-06
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Airvo 2 not suitable for CO2 clearance, awaiting Optiflow THRIVE machine
- **Last updated:** 2017-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02780518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02780518, "Airvo/Optiflow High Flow Nasal Oxygenation During Microlaryngeal Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02780518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*